Amplify Treat Test and AdvaGERMETF
13F holders, Q1 2024 (March 31)11holders
1famous investor
$18.40avg. 13F price*
At the end of Q1 2024, 11 institutions reported holding Amplify Treat Test and Adva (GERM) in their 13F filings. The largest holders were Susquehanna International Group, LLP ($761K), Citadel Advisors ($298K) and Federation des caisses Desjardins du Quebec ($27K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Amplify Treat Test and Adva
- CUSIP
- 032108581
- Latest filing quarter
- Q3 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 12 | $1.1M |
| Exits | 0 | $0 |
Ownership 11 holders
| Susquehanna International Group, LLP | 0.00% | New | 41,313 | $761K |
| Citadel Advisors | 0.00% | New | 16,176 | $298K |
| Federation des caisses Desjardins du Quebec | 0.00% | New | 1,500 | $27K |
| UBS Group AG | 0.00% | New | 988 | $18K |
| City Holding Co. | 0.00% | New | 400 | $7K |
| Osaic Holdings, Inc. | 0.00% | New | 392 | $7K |
| Bank of Montreal | 0.00% | New | 300 | $6K |
| Tucker Asset Management LLC | 0.00% | New | 231 | $4K |
| IFP Advisors, Inc | 0.00% | New | 200 | $4K |
| Steward Partners Investment Advisory, LLC | 0.00% | New | 160 | $3K |
| Royal Bank of Canada | 0.00% | New | 25 | $0 |
"% of holder's portfolio" is GERM's weight in each manager's 13F, not the share of Amplify Treat Test and Adva the manager owns.